Complete FDA and NHTSA recall records dated in January 2014.
These records include useful source details for the selected month.
Labeling: Label Mixup; NIFEDIPINE Capsule, 10 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL W/FLUORIDE, Chew Tablet, 1 mg (F), NDC 64376081501, Pedigree: AD22609_7, EXP:…
Labeling: Label Mixup; COENZYME Q-10 Capsule, 100 mg may be potentially mislabeled as ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: AD30180_13, EXP: 5/9/2014; ASPIRIN, Chew Tablet,…
Labeling:Label Mixup; VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: AD73652_10, EXP:…
Labeling: Label Mixup; FAMOTIDINE Tablet, 20 mg may be potentially mislabeled as CARVEDILOL PHOSPHATE ER, Capsule, 20 mg, NDC 00007337113, Pedigree: W003225, EXP: 6/17/2014; DULoxetine HCl…
Product which contains milk, soy, and wheat was distributed without an ingredient statement which declares their presence.
Product on hold pending FDA testing that found 0.015 ppm of the pesticide chlorafluazuron was inadvertently released to Safeway warehouses and a few retail stores.
Innovative Labs, LLC. has recalled two Dietary Supplements due to the presence of Chloramphenicol, an antimicrobial agent.
Potential presence of Chloramphenicol contamination
The product was not labeled with ingredients nor with an allergen declaration; the carton only contained one label which states the product identity by the second label with ingredients and…
Innovative Labs, LLC. has recalled two Dietary Supplements due to the presence of Chloramphenicol, an antimicrobial agent.
Potential for metal fragments in product after a single wire from metal detector was confirmed to be cut into fragments and not all pieces are accounted for.
Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice. Specifically, the labeling should read "If a severely depressed…
Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice. Specifically, the labeling should read "If a severely depressed…
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with…
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with…
Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice. Specifically, the labeling should read "If a severely depressed…
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with…
Presence of Foreign Substance; metal particulates were visually observed in the tablets.
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with…
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with…
The dietary supplements have the potential to be contaminated with undeclared steroids, pharmaceutical ingredients and/or chemical additives due to lack of GMPs.
The dietary supplements have the potential to be contaminated with undeclared steroids, pharmaceutical ingredients and/or chemical additives due to lack of GMPs.
The dietary supplements have the potential to be contaminated with undeclared steroids, pharmaceutical ingredients and/or chemical additives due to lack of GMPs.
Product was labeled as a medical food as opposed to a dietary supplement.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
